Notifications
2016_01_28 Data Snapshot
Table 1. Get Full Table
| Barcode | UUID | Date | Type | Category | Notes |
|---|---|---|---|---|---|
| TCGA-5L-AAT1 | 16fc3677-0393-4ed1-ad3f-c8355f056369 | 11/25/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | Patient had prior breast malignancy (in opposite breast) with systemic chemotherapy (Tamoxifen). |
| TCGA-A2-A0YT | 14b95463-2108-4921-afc2-e29eef52b18f | 08/19/2011 | BRCA | Neoadjuvant therapy | Subject is positive for neoadjuvant therapy. |
| TCGA-A2-A0YT | 14b95463-2108-4921-afc2-e29eef52b18f | 12/14/2010 | BRCA | Prior malignancy | Case had Prior malignancy |
| TCGA-A7-A0CD | 09765b0a-94f6-47d2-af56-93368084ac3a | 12/14/2010 | BRCA | Prior malignancy | Case had prior malignancy |
| TCGA-A7-A0DC | cb9f5e50-f49d-4899-8895-9367afcc1015 | 12/03/2014 | BRCA | Item does not meet study protocol | Tumor is DCIS and not invasive which is required by the TCGA BRCA study |
| TCGA-A8-A06T | 2c04a2f5-321e-4dea-8e00-268325da65cb | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A06U | 6bc4c56d-aac5-49a2-9913-9538d06d898f | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A07E | 853456d8-2367-404e-abc9-020fe8bbd209 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A084 | 3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9 | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-A8-A084 | 3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A08F | 0a017f15-1c6b-45e7-8d55-e0a71df1b2e8 | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-A8-A08F | 0a017f15-1c6b-45e7-8d55-e0a71df1b2e8 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A08S | 2779fa01-ac93-4e80-a997-3385f72172c3 | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-A8-A08S | 2779fa01-ac93-4e80-a997-3385f72172c3 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A091 | f39edd06-1016-4e8e-a42e-12f7e699ddc5 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A093 | 02f5ae33-a563-4ecb-9e33-dfa500a44931 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A09C | 80f3f48a-cc21-415c-b181-c77e7ba1c563 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A09E | dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-A8-A09E | dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A09I | 1557183c-aedd-4df6-b98a-3654667f7b69 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-A8-A09K | 6f959c92-b79f-4f84-9ee5-d07d3212d52d | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-A8-A09K | 6f959c92-b79f-4f84-9ee5-d07d3212d52d | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-AO-A0J5 | c1442467-d618-435f-8792-b1a18f696f1a | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-AO-A0JI | e17c565c-9857-4df3-a352-903b53093c85 | 10/28/2010 | BRCA | Prior malignancy | No Note Specified |
| TCGA-AQ-A04L-10A-01D-A10M-09 | a73828ae-0081-42cf-b3cb-a190e7b7f17b | 01/11/2013 | BRCA | Item is noncanonical | The BAM associated with TCGA-AQ-A04L-10A-01D-A12J-09 was derived from a pool of two aliquots: TCGA-AQ-A04L-10A-01D-A12J-09 and TCGA-AQ-A04L-10A-01D-A10M-09 |
| TCGA-AQ-A04L-10A-01D-A12J-09 | c2f7e5fb-0cff-43dd-959e-00f6b1d4b257 | 01/11/2013 | BRCA | Item is noncanonical | The BAM associated with TCGA-AQ-A04L-10A-01D-A12J-09 was derived from a pool of two aliquots: TCGA-AQ-A04L-10A-01D-A12J-09 and TCGA-AQ-A04L-10A-01D-A10M-09 |
| TCGA-AQ-A0Y5 | d0b78f3f-a198-437a-ab8c-204345d3b75d | 06/16/2014 | BRCA | Neoadjuvant therapy | systemic treatment |
| TCGA-AR-A2LL | 70fc011c-0f22-4026-9d72-87351126203a | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-AR-A2LR | d093173f-08ab-4138-bf3c-399c45a6e163 | 05/14/2015 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | Patient had prior primary breast cancer in the same breast as the TCGA primary and received chemotherapy (Adriamycin and Cytoxan) |
| TCGA-B6-A1KC-01A | 0cc10a1e-a90a-4c55-87a2-a74d47474a4a | 02/27/2014 | BRCA | Item does not meet study protocol | TCGA-B6-A1KC-01A was not pathology reviewed and should not be used. TCGA-B6-A1KC-01B should be used instead. |
| TCGA-BH-A0B6 | fa4e082a-d213-412e-8d91-842a6f4bef12 | 02/26/2015 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | During Enrollment it was found that patient recieved systemic tamoxifen 3 years prior to resection of TCGA tumor (left breast) for a prior right breast malignancy. |
| TCGA-BH-A0HM | (none) | 01/25/2013 | BRCA | Molecular analysis outside specification | No aliquots from subject UUID: 2d7390d0-4adf-44f4-a246-fb46bd56d34d should have been shipped, because DNA analyte UUID: b3edf23f-faad-4d53-808b-401bbd76445e failed to qualify at the BCR due to insufficient normal DNA yield. However, RNA aliquots TCGA-BH-A0HM-01A-11R-A10U-07 and TCGA-BH-A0HM-01A-11R-A10V-13 inadvertently shipped when RNA aliquot UUID: 737d212c-43cd-4925-a6a5-568964075a0d was incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10U-07 and RNA aliquot UUID: a979613c-5f14-47e9-a153-197552c289e6 was incorrectly assigned to TCGA-C4-A0EZ-01A-21R-A10V-13, which did pass for yield and QC. |
| TCGA-BH-A0HM-01A-11R-A10U-07 | (none) | 01/25/2013 | BRCA | Barcode incorrect | RNA aliquot UUID: 737d212c-43cd-4925-a6a5-568964075a0d is from a patient that failed to qualify at the BCR due to insufficient normal DNA yield, but inadvertently shipped when incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10U-07. |
| TCGA-BH-A0HM-01A-11R-A10V-13 | (none) | 01/25/2013 | BRCA | Barcode incorrect | RNA aliquot UUID: a979613c-5f14-47e9-a153-197552c289e6 is from a patient that failed to qualify at the BCR due to insufficient normal DNA yield, but inadvertently shipped when incorrectly assigned tcgaBarcode TCGA-C4-A0EZ-01A-21R-A10V-13. |
| TCGA-BH-A1F5 | e663954c-05a8-479a-a623-400c1eb5efc6 | 09/08/2015 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | The patient had a prior thyroid cancer (~28 years prior) and a prior lung cancer (~23 years prior) to the TCGA cancer procurement. The TSS does not know if radiation or chemotherapy was given which is unacceptable for TCGA. |
| TCGA-C8-A1HI | 444374f8-9282-439c-af00-0f828edcbff3 | 12/11/2014 | BRCA | Neoadjuvant therapy | During enrollment TSS discovered patient had 5FU, Epirubicin and cyclophosphamide prior to cancer procuemnt of the TCGA maliganncy. |
| TCGA-C8-A1HO | b3354b72-2637-4edc-9a95-e55801d3ac13 | 07/29/2015 | BRCA | Neoadjuvant therapy | The patient had neoadjuvant therapy (5-Fluorouracil, Epirubicin, and Cyclophosphamide) 2 months prior to TCGA cancer procurement. |
| TCGA-D8-A146 | 03da7a65-fa2f-42cb-a709-5fe8736f21d3 | 06/16/2014 | BRCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-EW-A2FW | e6f527a2-38eb-457e-bb39-3c5b9c0bcbec | 05/14/2015 | BRCA | Neoadjuvant therapy | Patient had hormone therapy (Exemestane) 2 months prior to TCGA specimen procurement |
| TCGA-GI-A2C8 | 33fe5833-d7a0-43d7-a03d-56985ea448a6 | 06/16/2014 | BRCA | Neoadjuvant therapy | systemic treatment |
| TCGA-LL-A6FP | 5c9d8163-a68e-43ce-9cba-effb7405761e | 06/11/2014 | BRCA | Neoadjuvant therapy | Patient recieved neoadjuvant therapy for the TCGA sample (Armidex). |